NCT05514002View on ClinicalTrials.gov

Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

PHASE4TerminatedINTERVENTIONAL
Enrollment

3,988

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Influenza, Human
Interventions
BIOLOGICAL

Fluzone Quadrivalent

Intramuscular

BIOLOGICAL

Flublok Quadrivalent

Intramuscular

Trial Locations (4)

32307

Florida A&M University, Tallahassee

77030

Baylor College of Medicine, Houston

84119

University of Utah, Salt Lake City

85724

University of Arizona, Tucson

Sponsors

Collaborators (1)

Westat
All Listed Sponsors
collaborator

Westat

OTHER

collaborator

University of Arizona

OTHER

collaborator

Florida A&M University

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

University of Utah

OTHER

lead

Fatimah Dawood

FED